Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Binovi Technologies Corp. EYCCF


Primary Symbol: BNVIF

Healthcare
Binovi Technologies Corp is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized knowledge, and big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. The company is working together under a common banner to help neuro-optometry, vision rehabilitation, a


GREY:BNVIF - Post by User

Binovi Technologies Corp. > scam
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(21)
•••
Comment by zerosummanon Feb 04, 2021 10:19am
47 Views
Post# 32469608

RE:scam

RE:scamLOL
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities